|
|
||||||||
1 Department of Health
Sciences,
Young
[n = 5, 30 ± 5 (SD) yr] and
middle-aged (n = 4, 58 ± 4 yr) men
and women performed single-leg knee-extension exercise inside a whole
body magnetic resonance system. Two trials were performed 7 days apart
and consisted of two 2-min bouts and a third bout continued to
exhaustion, all separated by 3 min of recovery.
31P spectra were used to determine
pH and relative concentrations of
Pi, phosphocreatine (PCr), and
-ATP every 10 s. The subjects consumed 0.3 g · kg
1 · day
1
of a placebo (trial 1) or creatine
(trial 2) for 5 days before each
trial. During the placebo trial, the middle-aged group had a lower
resting PCr compared with the young group (35.0 ± 5.2 vs. 39.5 ± 5.1 mmol/kg, P < 0.05) and a
lower mean initial PCr resynthesis rate (18.1 ± 3.5 vs. 23.2 ± 6.0 mmol · kg
1 · min
1,
P < 0.05). After creatine
supplementation, resting PCr increased 15%
(P < 0.05) in the young group and
30% (P < 0.05) in the middle-aged group to 45.7 ± 7.5 vs. 45.7 ± 5.5 mmol/kg, respectively. Mean initial PCr resynthesis rate also increased in the middle-aged group
(P < 0.05) to a level not different
from the young group (24.3 ± 3.8 vs. 24.2 ± 3.2 mmol · kg
1 · min
1).
Time to exhaustion was increased in both groups combined after creatine
supplementation (118 ± 34 vs. 154 ± 70 s,
P < 0.05). In conclusion, creatine
supplementation has a greater effect on PCr availability and
resynthesis rate in middle-aged compared with younger
persons.
aging; creatine monohydrate; phosphocreatine; skeletal muscle; magnetic resonance spectroscopy
This article has been cited by other articles:
![]() |
J. M. Tokish, M. S. Kocher, and R. J. Hawkins Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports Am. J. Sports Med., September 1, 2004; 32(6): 1543 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Smith, S. J. Montain, G. P. Zientara, and R. A. Fielding Use of phosphocreatine kinetics to determine the influence of creatine on muscle mitochondrial respiration: an in vivo 31P-MRS study of oral creatine ingestion J Appl Physiol, June 1, 2004; 96(6): 2288 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brose, G. Parise, and M. A. Tarnopolsky Creatine Supplementation Enhances Isometric Strength and Body Composition Improvements Following Strength Exercise Training in Older Adults J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2003; 58(1): B11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. LIU, H. ATAMNA, H. KURATSUNE, and B. N. AMES Delaying Brain Mitochondrial Decay and Aging with Mitochondrial Antioxidants and Metabolites Ann. N.Y. Acad. Sci., April 1, 2002; 959(1): 133 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Persky and G. A. Brazeau Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate Pharmacol. Rev., May 11, 2001; (2001) 1. [Abstract] [Full Text] |
||||
![]() |
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Smith, S. J. Montain, R. P. Matott, G. P. Zientara, F. A. Jolesz, and R. A. Fielding Effects of creatine supplementation on the energy cost of muscle contraction: a 31P-MRS study J Appl Physiol, July 1, 1999; 87(1): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Persky and G. A. Brazeau Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate Pharmacol. Rev., June 1, 2001; 53(2): 161 - 176. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |